Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4691008
SERIAL NO

06715418

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a process for the preparation of peptides of the formula I U--A.sup.1 --A.sup.2 13 A.sup.3 --A.sup.4 --A.sup.5 --X(I) in which U denotes a urethane protective group, A.sup.1 denotes Trp or D-Trp, A.sup.2 denotes Ser, Ala or Thr, A.sup.3 denotes Tyr or Phe, A.sup.4 denotes Gly, the residue of a D-amino acid or the residue of a D-amino acid derivative, A.sup.5 denotes Leu, N-methyl-Leu, N-ethyl-Leu, Ser(Bu.sup.t), Cys(But), Asp(OBu.sup.t), Glu(OBu.sup.t), Orn(Boc) or Lys(Boc) and X denotes OBu.sup.t or A.sup.6 --Pro--Y, where A.sup.6 represents Arg, Orn, Lys or homoarginine, and Y represents Gly--NH.sub.2, NH--NH--CO--NH.sub.2, (C.sub.1 -C.sub.3)-alkylamino, cyclopropylamino, (C.sub.1 -C.sub.3)-alkylamino which is substituted with hydroxyl or fluorine, or cycloalkylamino which is substituted with hydroxyl or fluorine, using tripeptides of the formula II, U--A.sup.1 --A.sup.2 --A.sup.3 --OH, in which the residues are defined as above. The invention also relates to peptides of the formula II as intermediates in this process.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVENTIS PHARMA DEUTSCHLAND GMBH (AVENTIS PHARMA)INDUSTRIEPARK HOCHST - GEBAUDE K 801 65926 FRANKFURT AM MAIN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Radscheit, Kurt Kelkheim, DE 1 4
Uhmann, Rainer Kriftel, DE 4 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation